Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HLA-mismatched Bone Marrow Transplantation”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Testing effectiveness (Phase 2)Study completedNCT02120157
What this trial is testing

Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies

Who this might be right for
Myeloablative ConditioningHLA-mismatched Bone Marrow TransplantationGraft Survival+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Looking for participantsNCT02828592
What this trial is testing

Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
Northside Hospital, Inc. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06802315
What this trial is testing

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia, Relapsed, AdultAcute Myeloid Leukemia RefractoryChronic Myeloid Leukemia - Accelerated Phase+1 more
University of Illinois at Chicago
Testing effectiveness (Phase 2)Study completedNCT01010217
What this trial is testing

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Who this might be right for
Blood Stem Cell Transplant FailureLeukemiaHematologic Malignancies
M.D. Anderson Cancer Center 176
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Testing effectiveness (Phase 2)Ended earlyNCT00489281
What this trial is testing

Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders

Who this might be right for
Sickle Cell Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 43
Testing effectiveness (Phase 2)Ended earlyNCT03246906
What this trial is testing

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+14 more
Fred Hutchinson Cancer Center 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05457556
What this trial is testing

Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMixed Phenotype Acute Leukemia+1 more
Children's Oncology Group 435
Testing effectiveness (Phase 2)UnknownNCT02799888
What this trial is testing

Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation

Who this might be right for
Graft-versus-host DiseaseHematopoietic Stem Cell Transplantation
Affiliated Hospital to Academy of Military Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT02793544
What this trial is testing

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Myelodysplastic Syndrome (MDS)Chronic Lymphocytic Leukemia (CLL)Chemotherapy-sensitive Lymphoma+4 more
Center for International Blood and Marrow Transplant Research 80
Testing effectiveness (Phase 2)Study completedNCT01251575
What this trial is testing

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more
Fred Hutchinson Cancer Center 77
Testing effectiveness (Phase 2)WithdrawnNCT00002790
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01221857
What this trial is testing

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+2 more
Gamida Cell ltd 12
Testing effectiveness (Phase 2)Study completedNCT01203722
What this trial is testing

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87
Testing effectiveness (Phase 2)UnknownNCT02519114
What this trial is testing

Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Maastricht University Medical Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT03465592
What this trial is testing

Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

Who this might be right for
SarcomaSolid Tumor, AdultSolid Tumor, Childhood
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 39
Not applicableEnded earlyNCT00578539
What this trial is testing

T-Reg Cell Kinetics, Stem Cell Transplant, REGALE

Who this might be right for
LeukemiaHodgkin LymphomaNon Hodgkin Lymphoma+1 more
Baylor College of Medicine 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04904588
What this trial is testing

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMixed Phenotype Acute Leukemia+5 more
Center for International Blood and Marrow Transplant Research 300
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Early research (Phase 1)WithdrawnNCT05170828
What this trial is testing

Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesT-lymphoblastic Lymphoma+4 more
Ossium Health, Inc.
Load More Results
38